[en] BACKGROUND: Uterine tumors resembling ovarian sex cord tumors (UTROSCTs) are rare neoplasms thought to be of putative endometrial stromal origin and solely composed of sex cord elements. Our study aimed to delineate the immunophenotype of these tumors and to verify whether their morphology reflects true sex cord-like differentiation. DESIGN: Representative paraffin blocks from 12 UTROSCTs were selected after confirmation of the diagnosis. Cords and/or trabeculae were seen in all tumors, whereas tubules, diffuse areas, and a retiform pattern were present in 9, 6, and 2 cases, respectively. Tumors were stained for sex cord (inhibin, calretinin, WT1, and melan-A), epithelial (KL1 and epithelial membrane antigen), and smooth muscle markers (smooth muscle actin, desmin, smooth muscle myosin heavy chain, h-caldesmon, and histone deacetylase-8), CD10, HMB45, S100, and CD117. Intensity and percentage of staining were recorded. RESULTS: Six out of 12 tumors were positive for sex cord markers (inhibin 3 of 12, calretinin 4 of 12, WT1 4 of 12, and melan-A 3 of 11) with 4 tumors coexpressing more than one marker. Half of the UTROSCTs showed positivity for KL1, with 2 tumors coexpressing epithelial membrane antigen. All but one tumor expressed one or more smooth muscle markers, with smooth muscle actin, desmin and histone deacetylase-8 being most commonly expressed. CD10 was positive in 6 of 12 tumors, CD117 in 4 of 12, and S100 in 2 of 11 tumors, whereas HMB45 was negative in 11 tumors tested. CONCLUSIONS: UTROSCTs have a diverse immunohistochemical profile often coexpressing sex cord, epithelial, and smooth muscle markers. The expression of smooth muscle markers in these tumors does not imply a smooth muscle origin as endometrial and sex cord stromal tumors are not infrequently positive for these markers. Positivity for sex cord markers supports a true sex cord/steroid phenotype. Although the immunohistochemical profile of these tumors overlaps with that of endometrial stromal tumors with sex cord-like differentiation as well as ovarian sex cord stromal tumors, the origin of UTROSCT remains uncertain.
Disciplines :
Oncology Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
de Leval, Laurence ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques - Département des sciences biomédicales et précliniques
Lim, Gkeok Stzuan Diana
Waltregny, David ; Université de Liège - ULiège > Département des sciences cliniques > Urologie - GIGA-R : Labo de recherche sur les métastases
Oliva, Esther
Language :
English
Title :
Diverse phenotypic profile of uterine tumors resembling ovarian sex cord tumors: an immunohistochemical study of 12 cases.
Adegboyega PA, Qiu S. Immunohistochemical profiling of cytoker-atin expression by endometrial stroma sarcoma. Hum Pathol. 2008;39:1459-1464.
Agoff SN, Grieco VS, Garcia R, et al. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol. 2001;9:164-169.
Aguirre P, Thor AD, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. An immunohistochemical study. Int J Gynecol Pathol. 1989;8:364-373.
Al-Hussaini M, Stockman A, Foster H, et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology. 2004;44:109-115.
Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998;29:498-504.
Baker P, Oliva E. Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques. J Clin Pathol. 2007;60:235-243.
Baker PM, Moch H, Oliva E. Unusual morphologic features of endometrial stromal tumors: a report of 2 cases. Am J Surg Pathol. 2005;29:1394-1398.
Baker RJ, Hildebrandt RH, Rouse RV, et al. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol. 1999;30:671-679.
Binder SW, Nieberg RK, Cheng L, et al. Histologic and immunohistochemical analysis of nine endometrial stromal tumors: an unexpected high frequency of keratin protein positivity. Int J Gynecol Pathol. 1991;10:191-197.
Bonazzi del Poggetto C, Virtanen I, Lehto VP, et al. Expression of intermediate filaments in ovarian and uterine tumors. Int J Gynecol Pathol. 1983;1:359-366.
Busam KJ, Iversen K, Coplan KA, et al. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. Am J Surg Pathol. 1998;22:57-63.
Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2001;20:346-352.
Cates JM, Coffing BN, Harris BT, et al. Calretinin expression in tumors of adipose tissue. Hum Pathol. 2006;37:312-321.
Clement PB, Scully RE. Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of fourteen cases. Am J Clin Pathol. 1976;66:512-525.
Costa MJ, Morris R, DeRose PB, et al. Histologic and immuno-histochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors. Arch Pathol Lab Med. 1993;117:802-808.
Czernobilsky B, Mamet Y, David MB, et al. Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors. Int J Gynecol Pathol. 2005;24:335-340.
de Leval L, Waltregny D, Boniver J, et al. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. Am J Surg Pathol. 2006;30:319-327.
Deavers MT, Malpica A, Liu J, et al. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol. 2003;16:584-590. (Pubitemid 36718440)
Devaney K, Tavassoli FA. Immunohistochemistry as a diagnostic aid in the interpretation of unusual mesenchymal tumors of the uterus. Mod Pathol. 1991;4:225-231.
Dickersin GRD, ed. Diagnostic Electron Microscopy: A Text/Atlas. New York: Igaku-Shoin; 1988:294.
Elmore LW, Domson K, Moore JR, et al. Expression of c-kit (CD117) in benign and malignant human endometrial epithelium. Arch Pathol Lab Med. 2001;125:146-151.
Farhood AI, Abrams J. Immunohistochemistry of endometrial stromal sarcoma. Hum Pathol. 1991;22:224-230.
Fekete PS, Vellios F, Patterson BD. Uterine tumor resembling an ovarian sex-cord tumor: report of a case of an endometrial stromal tumor with foam cells and ultrastructural evidence of epithelial differentiation. Int J Gynecol Pathol. 1985;4:378-387.
Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558-1575.
Foster MR, Johnson JE, Olson SJ, et al. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas. Arch Pathol Lab Med. 2001;125:1316-1320.
Franquemont DW, Frierson HF Jr, Mills SE. An immunohisto-chemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation. Am J Surg Pathol. 1991;15:861-870.
Geller MA, Argenta P, Bradley W, et al. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol. 2004;95:632-636.
Gersell DJ, Fulling KH. Localized neurofibromatosis of the female genitourinary tract. Am J Surg Pathol. 1989;13:873-878.
Goldstein NS, Bassi D, Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol. 2001;116:246-252.
Gulyas M, Hjerpe A. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J Pathol. 2003;199:479-487.
Gupta M, de Leval L, Selig M, et al. Uterine tumors resembling ovarian sex cord tumors: an ultrastructural analysis of 13 cases. Ultrastruct Pathol. 2010;34:16-24.
Hashi A, Yuminamochi T, Murata S, et al. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum. Int J Gynecol Pathol. 2003;22:374-377.
Hauptmann S, Nadjari B, Kraus J, et al. Uterine tumor resembling ovarian sex-cord tumorFa case report and review of the literature. Virchows Arch. 2001;439:97-101.
Hillard JB, Malpica A, Ramirez PT. Conservative management of a uterine tumor resembling an ovarian sex cord-stromal tumor. Gynecol Oncol. 2004;92:347-352.
Horn LC, Stegner HE. Uterine stromal tumor with ovarian sex cord differentiation. Pathologe. 1995;16:421-425.
Hurrell DP, McCluggage WG. Uterine tumour resembling ovarian sex cord tumour is an immunohistochemically polyphenotypic neoplasm which exhibits coexpression of epithelial, myoid and sex cord markers. J Clin Pathol. 2007;60:1148-1154.
Irving JA, Carinelli S, Prat J. Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation. Mod Pathol. 2006;19:17-24.
Iwata J, Fletcher CD. Immunohistochemical detection of cytoker-atin and epithelial membrane antigen in leiomyosarcoma: a systematic study of 100 cases. Pathol Int. 2000;50:7-14.
Kabbani W, Deavers MT, Malpica A, et al. Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol. 2003;22:297-302.
Kanamori T, Takakura K, Mandai M, et al. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol Hum Reprod. 2004;10:735-742.
Kantelip B, Cloup N, Dechelotte P. Uterine tumor resembling ovarian sex cord tumors: report of a case with ultrastructural study. Hum Pathol. 1986;17:91-94.
Keel SB, Clement PB, Prat J, et al. Malignant schwannoma of the uterine cervix: a study of three cases. Int J Gynecol Pathol. 1998; 17:223-230.
Klein WM, Kurman RJ. Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary. Int J Gynecol Pathol. 2003;22:181-184.
Kommoss F, Oliva E, Bhan AK, et al. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol. 1998;11:656-664.
Krishnamurthy S, Jungbluth AA, Busam KJ, et al. Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation. Am J Surg Pathol. 1998;22:1078-1082.
Kuruvila S, Samarasinghe D, Thomas S. Uterine neoplasm resembling an ovarian sex cord tumor. Saudi Med J. 2003;24: 221-223.
Kuscu E, Oktem M, Karahan H, et al. Sclerosing stromal tumor of the ovary: a case report. Eur J Gynaecol Oncol. 2003;24:442-444. (Pubitemid 37236576)
Leath CA III, Straughn JM Jr, Conner MG, et al. Immunohisto-chemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series. J Reprod Med. 2004;49:71-75.
Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res. 2001;264:74-99.
Lillemoe TJ, Perrone T, Norris HJ, et al. Myogenous phenotype of epithelial-like areas in endometrial stromal sarcomas. Arch Pathol Lab Med. 1991;115:215-219.
Logani S, Oliva E, Amin MB, et al. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications. Am J Surg Pathol. 2003;27:1434-1441.
Longtine JA, Pinkus GS, Fujiwara K, et al. Immunohistochemical localization of smooth muscle myosin in normal human tissues. J Histochem Cytochem. 1985;33:179-184.
Loo KT, Leung AK, Chan JK. Immunohistochemical staining of ovarian granulosa cell tumours with MIC2 antibody. Histopathology. 1995;27:388-390.
Lugli A, Forster Y, Haas P, et al. Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol. 2003;34:994-1000.
Mai KT, Teo I, Al Moghrabi H, et al. Calretinin and CD34 immunoreactivity of the endometrial stroma in normal endome-trium and change of the immunoreactivity in dysfunctional uterine bleeding with evidence of "disordered endometrial stroma." Pathology. 2008;40:493-499.
McCluggage WG. Uterine tumours resembling ovarian sex cord tumours: immunohistochemical evidence for true sex cord differentiation. Histopathology. 1999;34:375-376.
McCluggage WG. Value of inhibin staining in gynecological pathology. Int J Gynecol Pathol. 2001;20:79-85.
McCluggage WG, Maxwell P. Adenocarcinomas of various sites may exhibit immunoreactivity with anti-inhibin antibodies. Histopathology. 1999;35:216-220.
McCluggage WG, Shah V, Walsh MY, et al. Uterine tumour resembling ovarian sex cord tumour: evidence for smooth muscle differentiation. Histopathology. 1993;23:83-85.
McCluggage WG, Date A, Bharucha H, et al. Endometrial stromal sarcoma with sex cord-like areas and focal rhabdoid differentiation. Histopathology. 1996;29:369-374.
McCluggage WG, Burton J, Maxwell P, et al. Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin. J Clin Pathol. 1998;51:114-116.
McGettigan CP, Armstrong G, Saleh N, et al. Malignant melanoma of the uterus diagnosed at hysteroscopy. J Obstet Gynaecol. 2006; 26:383-385.
Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol. 2002;26:1477-1483.
Nogales F, Tavassoli FA. Sex cord-like, neuroectodermal and neuroendocrine tumours, lyphomas and leukaemias. In: Tavassoli FA, Devilee P, ed. WHO Classifications of Tumours, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyons: International Agency for Research on Cancer; 2003:255.
Nogales FF, Isaac MA. Functioning uterine sex cord tumour. Histopathology. 2002;41:277-279.
Nucci MR, O'Connell JT, Huettner PC, et al. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol. 2001;25: 455-463.
Ohta Y, Suzuki T, Kojima M, et al. Low-grade endometrial stromal sarcoma with an extensive epithelial-like element. Pathol Int. 2003;53:246-251.
Oliva E, Young RH, Amin MB, et al. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol. 2002;26:403-412.
Oliva E, Wang WL, Branton P. Expression of melanocytic ("PEComa") markers in smooth muscle tumors of the uterus: an immunohistochemical analysis of 86 cases. Mod Pathol. 2006; 19:191A.
Oliva E, Alvarez T, Young RH. Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2005;29:143-156.
Oliva E, Garcia-Miralles N, Vu Q, et al. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohis-tochemical analysis of 101 cases. Int J Gynecol Pathol. 2007;26: 359-367.
Otis CN, Powell JL, Barbuto D, et al. Intermediate filamentous proteins in adult granulosa cell tumors. An immunohistochemical study of 25 cases. Am J Surg Pathol. 1992;16:962-968.
Pusiol T, Parolari AM, Piscioli F. Uterine leiomyoma with tubules. Int Semin Surg Oncol. 2008;5:15.
Renshaw AA, Gordon M, Corless CL. Immunohistochemistry of unclassified sex cord-stromal tumors of the testis with a predominance of spindle cells. Mod Pathol. 1997;10:693-700.
Rishi M, Howard LN, Bratthauer GL, et al. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol. 1997;21:583-589.
Rush DS, Tan J, Baergen RN, et al. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol. 2001;25: 253-258.
Santini D, Ceccarelli C, Leone O, et al. Smooth muscle differentiation in normal human ovaries, ovarian stromal hyperplasia and ovarian granulosa-stromal cells tumors. Mod Pathol. 1995;8:25-30.
Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998;11:728-734.
Schraith DF, Hahm GK, Niemann TH, et al. Alpha-inhibin immunoreactivity in soft-tissue neoplasia. Mod Pathol. 2003;16: 1205-1209.
Seidman JD, Abbondanzo SL, Bratthauer GL. Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity. Int J Gynecol Pathol. 1995;14:331-338.
Shah VI, Freites ON, Maxwell P, et al. Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. J Clin Pathol. 2003;56:221-224.
Silva EG, Bodurka DC, Scouros MA, et al. A uterine leiomyo-sarcoma that became positive for HMB45 in the metastasis. Ann Diagn Pathol. 2005;9:43-45.
Simeone S, Laterza MM, Scaravilli G, et al. Malignant melanoma metastasizing to the uterus in a patient with atypical postmenopause metrorrhagia. A case report. Minerva Ginecol. 2009;61:77-80.
Simpson KW, Albores-Saavedra J. HMB-45 reactivity in conventional uterine leiomyosarcomas. Am J Surg Pathol. 2007;31:95-98.
Soslow RA, Ali A, Oliva E. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases. Am J Surg Pathol. 2008; 32:1013-1021.
Staats PN, Garcia JJ, Dias-Santagata DC, et al. Uterine tumors resembling ovarian sex cord tumors (UTROSCT) lack the JAZF1-JJAZ1 translocation frequently seen in endometrial stromal tumors. Am J Surg Pathol. 2009;33:1206-1212.
Stewart CJ, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Histopathology. 1997;31:67-74.
Stewart CJ, Nandini CL, Richmond JA. Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours. J Clin Pathol. 2000;53:206-211.
Sutak J, Lazic D, Cullimore JE. Uterine tumour resembling an ovarian sex cord tumour. J Clin Pathol. 2005;58:888-890.
Suzuki C, Matsumoto T, Fukunaga M, et al. Uterine tumors resembling ovarian sex-cord tumors producing parathyroid hormone-related protein of the uterine cervix. Pathol Int. 2002;52: 164-168.
Tanaka Y, Carney JA, Ijiri R, et al. Utility of immunostaining for S-100 protein subunits in gonadal sex cord-stromal tumors, with emphasis on the large-cell calcifying Sertoli cell tumor of the testis. Hum Pathol. 2002;33:285-289.
Tiltman AJ, Haffajee Z. Sclerosing stromal tumors, thecomas, and fibromas of the ovary: an immunohistochemical profile. Int J Gynecol Pathol. 1999;18:254-258.
Vang R, Kempson RL. Perivascular epithelioid cell tumor ("PEComa") of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol. 2002;26:1-13.
Wei EX, Albores-Saavedra J, Fowler MR. Plexiform neurofibroma of the uterine cervix: a case report and review of the literature. Arch Pathol Lab Med. 2005;129:783-786.
Yilmaz A, Rush DS, Soslow RA. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol. 2002;26:1142-1150.
Zhang PJ, Goldblum JR, Pawel BR, et al. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol. 2003;16:229-235.
Zhao C, Bratthauer GL, Barner R, et al. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: a study of 160 cases. Am J Surg Pathol. 2007;31:255-266.
